Spinal Muscular Atrophies-Reference-Cited by-同舟云学术

Spinal Muscular Atrophies

Published:2015-06 Issue:3 Volume:62 Page:743-766
ISSN:0031-3955
Container-title:Pediatric Clinics of North America
language:en
Short-container-title:Pediatric Clinics of North America

Author:

Darras Basil T.

Funder

Spinal Muscular Atrophy Foundation

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology and Child Health

Reference116 articles.

1. Two early infantile hereditary cases of progressive muscular atrophy simulating dystrophy, but on a neural basis [article in German];Werdnig;Arch Psychiat Neurol,1891

2. Ueber chronische spinale Muskelatrophie im Kindesalter, auf familiärer Basis;Hoffmann;Dtsch Z Nervenheilkd,1893

3. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2;Monani;Hum Mol Genet,1999

4. Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy;Pearn;J Med Genet,1978

5. Genetic risk assessment in carrier testing for spinal muscular atrophy;Ogino;Am J Med Genet,2002

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the Efficacy of Nusinersen Treatment in Patients with Late-onset SMA Using the Hammersmith Functional Motor Scale Expanded;Journal of Dr Behcet Uz Children s Hospital;2024-08-27

2. Quality of Life Assessment in Romanian Patients with Spinal Muscular Atrophy Undergoing Nusinersen Treatment;Neurology International;2024-08-26

3. Nusinersen Improves Motor Function in Type 2 and 3 Spinal Muscular Atrophy Patients across Time;Biomedicines;2024-08-06

4. The prevalence of SMN gene deletion/duplication in spinal muscular atrophy families referred to neuro-genetic centers of Mashhad, Iran;Egyptian Journal of Medical Human Genetics;2024-07-31

5. Recent Progress in Gene-Targeting Therapies for Spinal Muscular Atrophy: Promises and Challenges;Genes;2024-07-30